Literature DB >> 1125555

Editorial: Screening of the newborn for Duchenne muscular dystrophy.

.   

Abstract

Entities:  

Keywords:  Genetics and Reproduction

Mesh：

Substances：

Year:  1975        PMID： 1125555      PMCID： PMC1681830          DOI： 10.1136/bmj.2.5968.403

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  6 in total

1.  Serum enzymes in muscular dystrophy and certain other muscular and neuromuscular diseases. I. Serum glutamic oxalacetic transaminase.

Authors:  C M PEARSON
Journal:  N Engl J Med       Date:  1957-06-06       Impact factor: 91.245

2.  Creatine kinase activity in the umbilical cord blood of aborted fetuses.

Authors:  P F Larson; D C Park
Journal:  J Neurol Sci       Date:  1974-09       Impact factor: 3.181

3.  The activity of ATP: creatine phosphotransferase (E.C.2.7.3.2) in umbilical cord blood.

Authors:  P D Griffiths
Journal:  Clin Chim Acta       Date:  1968       Impact factor: 3.786

4.  Screening for inherited diseases.

Authors:  C A Janeway
Journal:  N Engl J Med       Date:  1971-04-08       Impact factor: 91.245

5.  [Enzyme activity determination in progressive muscular dystrophy. IV. Serum enzymatic kinetics in the preclinical stage of the Duchenne type during the 1st 2 years of life].

Authors:  H Heyck; G Laudahn; P M Carsten
Journal:  Klin Wochenschr       Date:  1966-06-15

6.  Newborn screening for Duchenne muscular dystrophy.

Authors:  H Zellweger; A Antonik
Journal:  Pediatrics       Date:  1975-01       Impact factor: 7.124
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.